TIMOTHY MCINERNEY

Profile

First Name

: TIMOTHY

Middle Name

:

Last Name

: MCINERNEY

Related Companies
Titles
Company Name
Related People
DIRECTOR
ZIOPHARM ONCOLOGY INC
JASON A. AMELLO, RICHARD E BAGLEY, CAESAR BELBEL, CAESAR J. BELBEL, SCOTT BRAUNSTEIN, MURRAY BRENNAN, JILL BUCK, JAMES CANNON, JAMES A. CANNON, JAMES ANTHONY CANNON, LAURENCE J.N. COOPER, ELEANOR DE GROOT, ELAN Z. EZICKSON, WYCHE FOWLER, WYCHE FOWLER, JR., GARY S FRAGIN, ROBERT HADFIELD, HEIDI HAGEN, RANDAL KIRK, RANDAL J KIRK, RANDAL J. KIRK, KEVIN LAFOND, KEVIN G. LAFOND, FRANCOIS LEBEL, JONATHAN LEWIS, DAVID MAUNEY, DAVID M. MAUNEY, DOUGLAS W. PAGAN, SATH SHUKLA, SCOTT TARRIFF, MICHAEL WEISER, HAGOP YOUSSOUFIAN
DIRECTOR
MANHATTAN PHARMACEUTICALS INC
DOUGLAS ABEL, NEIL HERSKOWITZ, MICHAEL MCGUINNESS, SEAN POWER, RICHARD STEINHART, MICHAEL WEISS
DIRECTOR
EDGEMONT PHARMACEUTICALS, LLC
CHRISTINE BLUMHARDT, BARBARA DUNCAN, DOUGLAS A. SALTEL, WARREN STERN, MIKE VACHON, ROBERT ZERBE
DIRECTOR
INSITE VISION INC
RICK ANDERSON, LYLE M. BOWMAN, LOUIS DRAPEAU, KAMRAN HOSSEINI, BRIAN LEVY, TIMOTHY P. LYNCH, EVAN S. MELROSE, ROBERT O-HOLLA, SURENDRA PATEL, TIMOTHY RUANE, CRAIG TOOMAN, ANTHONY YOST, ANTHONY J. YOST
DIRECTOR
EMISPHERE TECHNOLOGIES INC
MICHAEL GARONE, MICHAEL R. GARONE, JOHN HARKEY, JOHN D. HARKEY, MICHAEL NOVINSKI, JACOB M. PLOTSKER, MARK RACHESKY, MARK H. RACHESKY, TIMOTHY ROTHWELL, TIMOTHY G. ROTHWELL, ALAN L. RUBINO, MICHAEL WEISER
PROMOTER
QSPEX TECHNOLOGIES INC
WILLIAM ANTON, BRETT CRAIG, GLEN ELLISOR, GLENN ELLISOR, JAMES GROOTEGOED, JOHN LOWERY, JOHN LOWRY, STEPHEN MARTIN, EVAN MELROSE, KAREN REID, KAI SU, MARTIN SUTTER, MARTIN P. SUTTER
DIRECTOR
CORINO THERAPEUTICS, INC.
PETER BARBER, DANIEL DIPIETRO, JAY MOORIN
DIRECTOR
PLEOPHARMA, INC.
PAUL BISARO, DANIEL ALAN CARTWRIGHT, DANIEL CARTWRITGHT, GINGER CONSTANTINE, JAY CONSTANTINE, ROBERT FINIZIO, SARAH HASSAN, BISARO PAUL, THOMAS POCHE, THOMAS F POCHE, BRIJ SHARMA, THOMPSON TOMMY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-08-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-23 
2017-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-04-13 
2017-04-06
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-31 
2016-12-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-10 
2016-09-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-31 
2015-07-17
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-10-11 
2015-01-28
D
Link
BIOTECHNOLOGY 
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] 
DECLINE TO DISCLOSE 
Equity 
2015-01-13 
2014-12-02
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-10-11 
2014-10-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-10-09 
2013-05-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-05-07 
2012-11-21
D
Link
PHARMACEUTICALS 
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] 
DECLINE TO DISCLOSE 
Equity 
2012-11-07 
2011-07-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-07-12 
2011-01-14
D
Link
PHARMACEUTICALS 
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] 
NO REVENUES 
Equity 
2011-01-12 
2010-12-09
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-03-22 
2010-04-06
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-03-22 
2010-03-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-03-02 
2009-09-29
D
Link
PHARMACEUTICALS 
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] 
NO REVENUES 
Equity 
2009-09-15